These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8287973)

  • 1. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein.
    Malo-Ranta U; Ylä-Herttuala S; Metsä-Ketelä T; Jaakkola O; Moilanen E; Vuorinen P; Nikkari T
    FEBS Lett; 1994 Jan; 337(2):179-83. PubMed ID: 8287973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
    Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
    Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein.
    Neugarten J; Ghossein C; Silbiger S
    J Lab Clin Med; 1995 Oct; 126(4):385-91. PubMed ID: 7561448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of low density lipoprotein by bovine and porcine aortic endothelial cells and porcine endocardial cells in culture.
    Morgan J; Smith JA; Wilkins GM; Leake DS
    Atherosclerosis; 1993 Sep; 102(2):209-16. PubMed ID: 8251007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries.
    Zhang Y; Zhang W; Edvinsson L; Xu CB
    Eur J Pharmacol; 2014 Feb; 725():10-7. PubMed ID: 24444440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion.
    Müller K; Carpenter KL; Mitchinson MJ
    Free Radic Res; 1998 Sep; 29(3):207-20. PubMed ID: 9802552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
    Parthasarathy S; Barnett J; Fong LG
    Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular macrophages in nephrotoxic serum nephritis are activated to oxidize low-density lipoprotein.
    Rie J; Silbiger S; Neugarten J
    Am J Kidney Dis; 1995 Aug; 26(2):362-7. PubMed ID: 7645542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors.
    Hogg N; Struck A; Goss SP; Santanam N; Joseph J; Parthasarathy S; Kalyanaraman B
    J Lipid Res; 1995 Aug; 36(8):1756-62. PubMed ID: 7595096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism.
    Mukhopadhyay CK; Ehrenwald E; Fox PL
    J Biol Chem; 1996 Jun; 271(25):14773-8. PubMed ID: 8663020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low-density lipoprotein.
    Ji Y; Diao J; Han Y; Huang Y; Bai H; Chen Q; Fan L; Ferro A
    Atherosclerosis; 2006 Sep; 188(1):84-94. PubMed ID: 16300769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein.
    Viita H; Närvänen O; Ylä-Herttuala S
    Life Sci; 1999; 65(8):783-93. PubMed ID: 10466744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
    Niu XL; Xia Y; Hoshiai K; Tanaka K; Sawamura S; Nakazawa H
    Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis.
    Hogg N; Kalyanaraman B; Joseph J; Struck A; Parthasarathy S
    FEBS Lett; 1993 Nov; 334(2):170-4. PubMed ID: 8224243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages.
    Mohan PF; Desaiah D
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1047-54. PubMed ID: 7980576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative and malondialdehyde modification of low-density lipoprotein: a comparative study of binding and degradation by macrophages and endothelial cells.
    Zhou M; Chen Y; Liu S; Ding Z; Pang Z; Wan J
    Br J Biomed Sci; 1998 Sep; 55(3):192-8. PubMed ID: 10367404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion.
    Pritchard KA; Groszek L; Smalley DM; Sessa WC; Wu M; Villalon P; Wolin MS; Stemerman MB
    Circ Res; 1995 Sep; 77(3):510-8. PubMed ID: 7543827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of resveratrol on oxidative modification of human low density lipoprotein.
    Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
    Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of natural polyphenol compounds on the oxidative modification of low-density lipoproteins].
    Dushkin MI; Zykov AA; Pivovarova EN
    Biull Eksp Biol Med; 1993 Oct; 116(10):393-5. PubMed ID: 8117961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.